Current location - Trademark Inquiry Complete Network - Tian Tian Fund - ETF tracking: Yesterday, the ETF net inflow was 9 million yuan, and the fund was "bottom-hunting" to create 5 ETFs.
ETF tracking: Yesterday, the ETF net inflow was 9 million yuan, and the fund was "bottom-hunting" to create 5 ETFs.

Yesterday (November 29th), the turnover of the two cities was 968.1 billion, which was 228.2 billion more than the previous trading day. Choice data shows that there were 261 million net redemptions of equity ETFs in the market yesterday, including 711 million net redemptions of equity ETFs in Shanghai and 45 million net subscriptions of equity ETFs in Shenzhen. Based on the latest net value, the net purchase amount in the market yesterday reached 922 million yuan.

real estate ETF funds led the gains

Data show that among the stock ETFs in the market yesterday, real estate ETF funds, real estate ETF funds and financial ETF funds were among the top gainers, among which real estate ETF funds rose by 1.4%, ranking first.

kechuang 5ETF has the largest subscription

yesterday, the largest net subscription amount was kechuang 5ETF, with a net subscription amount of 1.74 billion. In addition, CSI 5ETF Fund and CSI 1ETF Fund were also among the top purchasers, with net subscription amounts of 729 million yuan and 591 million yuan respectively.

SSE 5ETF was redeemed

The data also showed that SSE 5ETF was the largest on-market stock ETF with a redemption amount of 1.287 billion yuan yesterday, followed by securities ETF with a redemption amount of 735 million yuan.

institutions look at the market outlook

Everbright Securities believes that the A-share inflection point has arrived, and the short-term layout of flexible varieties continues to be optimistic about the market counterattack. For the current market, the core improvement comes from the expected change of epidemic prevention and control, but looking forward to the future, this is not the only positive thing that the market can see, and the market may see favorable factors including but not limited to epidemic improvement one after another. < P > It mainly includes: 1) The epidemic prevention and control measures may be optimized, improved and adjusted according to the situation; 2) The real estate policy and sales data may be further marginally improved; 3) The economic data in November and December may rebound; 4) The overseas risks may gradually ease, and the northbound capital will return to a state of continuous net inflow. And this series of factors will push the market to continue to rise. Therefore, we believe that the current market turning point has arrived, and we continue to be optimistic about the market counterattack.

The agency pointed out that the short-term layout of flexible varieties. We believe that the performance of various industries will be more balanced in the short term when the market rebounds. It mainly focuses on two main lines. One is the main line of elastic varieties, which mainly includes building materials, food and beverage, electronics, automobiles, power equipment, medicine and biology. Second, the security main line of marginal policy improvement, mainly including electronics, computers, national defense and military industries.

Pay attention to the pharmaceutical and consumption sectors in the medium term: 1) According to the third quarterly report, the performance of the downstream sector has improved significantly. In the future, with the gradual easing of epidemic disturbance and real estate pressure, consumption is expected to recover further, and the consumption sector is expected to usher in an inflection point. In the specific configuration direction, it is suggested to pay attention to food and beverage, household appliances, retail, social services and other industries; 2) Recently, domestic favorable policies for the pharmaceutical sector have appeared frequently. In addition, the allocation ratio of partial stock funds to pharmaceutical organisms is currently at a historical low level, and the strategic opportunities of the pharmaceutical sector deserve attention.